Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Monoclonal Antibodies market report explains the definition, types, applications, major countries, and major players of the Monoclonal Antibodies market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
MedImmune
mmunogen
Eli Lilly
Novartis
BMS
Formation Biologics
Human Genome Sciences
Pfizer
Stemcentrx
Synthon Biopharmaceuticals
GlaxoSmithKline
Amgen
Genmab
Roche
Teva
Merck
Seattle Genetics
AbbVie
Takeda
Johnson & Johnson
By Type:
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others
By End-User:
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Monoclonal Antibodies Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Monoclonal Antibodies Outlook to 2028- Original Forecasts
-
2.2 Monoclonal Antibodies Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Monoclonal Antibodies Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Monoclonal Antibodies Market- Recent Developments
-
6.1 Monoclonal Antibodies Market News and Developments
-
6.2 Monoclonal Antibodies Market Deals Landscape
7 Monoclonal Antibodies Raw Materials and Cost Structure Analysis
-
7.1 Monoclonal Antibodies Key Raw Materials
-
7.2 Monoclonal Antibodies Price Trend of Key Raw Materials
-
7.3 Monoclonal Antibodies Key Suppliers of Raw Materials
-
7.4 Monoclonal Antibodies Market Concentration Rate of Raw Materials
-
7.5 Monoclonal Antibodies Cost Structure Analysis
-
7.5.1 Monoclonal Antibodies Raw Materials Analysis
-
7.5.2 Monoclonal Antibodies Labor Cost Analysis
-
7.5.3 Monoclonal Antibodies Manufacturing Expenses Analysis
8 Global Monoclonal Antibodies Import and Export Analysis (Top 10 Countries)
-
8.1 Global Monoclonal Antibodies Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Monoclonal Antibodies Export by Region (Top 10 Countries) (2017-2028)
9 Global Monoclonal Antibodies Market Outlook by Types and Applications to 2022
-
9.1 Global Monoclonal Antibodies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Infection Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hematological Diseases Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Monoclonal Antibodies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Autoimmune and inflammatory diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Respiratory diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ophthalmology Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Monoclonal Antibodies Market Analysis and Outlook till 2022
-
10.1 Global Monoclonal Antibodies Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Monoclonal Antibodies Consumption (2017-2022)
-
10.2.2 Canada Monoclonal Antibodies Consumption (2017-2022)
-
10.2.3 Mexico Monoclonal Antibodies Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Monoclonal Antibodies Consumption (2017-2022)
-
10.3.2 UK Monoclonal Antibodies Consumption (2017-2022)
-
10.3.3 Spain Monoclonal Antibodies Consumption (2017-2022)
-
10.3.4 Belgium Monoclonal Antibodies Consumption (2017-2022)
-
10.3.5 France Monoclonal Antibodies Consumption (2017-2022)
-
10.3.6 Italy Monoclonal Antibodies Consumption (2017-2022)
-
10.3.7 Denmark Monoclonal Antibodies Consumption (2017-2022)
-
10.3.8 Finland Monoclonal Antibodies Consumption (2017-2022)
-
10.3.9 Norway Monoclonal Antibodies Consumption (2017-2022)
-
10.3.10 Sweden Monoclonal Antibodies Consumption (2017-2022)
-
10.3.11 Poland Monoclonal Antibodies Consumption (2017-2022)
-
10.3.12 Russia Monoclonal Antibodies Consumption (2017-2022)
-
10.3.13 Turkey Monoclonal Antibodies Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Monoclonal Antibodies Consumption (2017-2022)
-
10.4.2 Japan Monoclonal Antibodies Consumption (2017-2022)
-
10.4.3 India Monoclonal Antibodies Consumption (2017-2022)
-
10.4.4 South Korea Monoclonal Antibodies Consumption (2017-2022)
-
10.4.5 Pakistan Monoclonal Antibodies Consumption (2017-2022)
-
10.4.6 Bangladesh Monoclonal Antibodies Consumption (2017-2022)
-
10.4.7 Indonesia Monoclonal Antibodies Consumption (2017-2022)
-
10.4.8 Thailand Monoclonal Antibodies Consumption (2017-2022)
-
10.4.9 Singapore Monoclonal Antibodies Consumption (2017-2022)
-
10.4.10 Malaysia Monoclonal Antibodies Consumption (2017-2022)
-
10.4.11 Philippines Monoclonal Antibodies Consumption (2017-2022)
-
10.4.12 Vietnam Monoclonal Antibodies Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Monoclonal Antibodies Consumption (2017-2022)
-
10.5.2 Colombia Monoclonal Antibodies Consumption (2017-2022)
-
10.5.3 Chile Monoclonal Antibodies Consumption (2017-2022)
-
10.5.4 Argentina Monoclonal Antibodies Consumption (2017-2022)
-
10.5.5 Venezuela Monoclonal Antibodies Consumption (2017-2022)
-
10.5.6 Peru Monoclonal Antibodies Consumption (2017-2022)
-
10.5.7 Puerto Rico Monoclonal Antibodies Consumption (2017-2022)
-
10.5.8 Ecuador Monoclonal Antibodies Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Monoclonal Antibodies Consumption (2017-2022)
-
10.6.2 Kuwait Monoclonal Antibodies Consumption (2017-2022)
-
10.6.3 Oman Monoclonal Antibodies Consumption (2017-2022)
-
10.6.4 Qatar Monoclonal Antibodies Consumption (2017-2022)
-
10.6.5 Saudi Arabia Monoclonal Antibodies Consumption (2017-2022)
-
10.6.6 United Arab Emirates Monoclonal Antibodies Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Monoclonal Antibodies Consumption (2017-2022)
-
10.7.2 South Africa Monoclonal Antibodies Consumption (2017-2022)
-
10.7.3 Egypt Monoclonal Antibodies Consumption (2017-2022)
-
10.7.4 Algeria Monoclonal Antibodies Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Monoclonal Antibodies Consumption (2017-2022)
-
10.8.2 New Zealand Monoclonal Antibodies Consumption (2017-2022)
11 Global Monoclonal Antibodies Competitive Analysis
-
11.1 MedImmune
-
11.1.1 MedImmune Company Details
-
11.1.2 MedImmune Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 MedImmune Monoclonal Antibodies Main Business and Markets Served
-
11.1.4 MedImmune Monoclonal Antibodies Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 mmunogen
-
11.2.1 mmunogen Company Details
-
11.2.2 mmunogen Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 mmunogen Monoclonal Antibodies Main Business and Markets Served
-
11.2.4 mmunogen Monoclonal Antibodies Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Eli Lilly
-
11.3.1 Eli Lilly Company Details
-
11.3.2 Eli Lilly Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Eli Lilly Monoclonal Antibodies Main Business and Markets Served
-
11.3.4 Eli Lilly Monoclonal Antibodies Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Novartis
-
11.4.1 Novartis Company Details
-
11.4.2 Novartis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Novartis Monoclonal Antibodies Main Business and Markets Served
-
11.4.4 Novartis Monoclonal Antibodies Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 BMS
-
11.5.1 BMS Company Details
-
11.5.2 BMS Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 BMS Monoclonal Antibodies Main Business and Markets Served
-
11.5.4 BMS Monoclonal Antibodies Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Formation Biologics
-
11.6.1 Formation Biologics Company Details
-
11.6.2 Formation Biologics Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Formation Biologics Monoclonal Antibodies Main Business and Markets Served
-
11.6.4 Formation Biologics Monoclonal Antibodies Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Human Genome Sciences
-
11.7.1 Human Genome Sciences Company Details
-
11.7.2 Human Genome Sciences Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Human Genome Sciences Monoclonal Antibodies Main Business and Markets Served
-
11.7.4 Human Genome Sciences Monoclonal Antibodies Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Pfizer
-
11.8.1 Pfizer Company Details
-
11.8.2 Pfizer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Pfizer Monoclonal Antibodies Main Business and Markets Served
-
11.8.4 Pfizer Monoclonal Antibodies Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Stemcentrx
-
11.9.1 Stemcentrx Company Details
-
11.9.2 Stemcentrx Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Stemcentrx Monoclonal Antibodies Main Business and Markets Served
-
11.9.4 Stemcentrx Monoclonal Antibodies Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Synthon Biopharmaceuticals
-
11.10.1 Synthon Biopharmaceuticals Company Details
-
11.10.2 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Synthon Biopharmaceuticals Monoclonal Antibodies Main Business and Markets Served
-
11.10.4 Synthon Biopharmaceuticals Monoclonal Antibodies Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 GlaxoSmithKline
-
11.11.1 GlaxoSmithKline Company Details
-
11.11.2 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 GlaxoSmithKline Monoclonal Antibodies Main Business and Markets Served
-
11.11.4 GlaxoSmithKline Monoclonal Antibodies Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Amgen
-
11.12.1 Amgen Company Details
-
11.12.2 Amgen Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Amgen Monoclonal Antibodies Main Business and Markets Served
-
11.12.4 Amgen Monoclonal Antibodies Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Genmab
-
11.13.1 Genmab Company Details
-
11.13.2 Genmab Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Genmab Monoclonal Antibodies Main Business and Markets Served
-
11.13.4 Genmab Monoclonal Antibodies Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Roche
-
11.14.1 Roche Company Details
-
11.14.2 Roche Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Roche Monoclonal Antibodies Main Business and Markets Served
-
11.14.4 Roche Monoclonal Antibodies Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Teva
-
11.15.1 Teva Company Details
-
11.15.2 Teva Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Teva Monoclonal Antibodies Main Business and Markets Served
-
11.15.4 Teva Monoclonal Antibodies Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Merck
-
11.16.1 Merck Company Details
-
11.16.2 Merck Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Merck Monoclonal Antibodies Main Business and Markets Served
-
11.16.4 Merck Monoclonal Antibodies Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Seattle Genetics
-
11.17.1 Seattle Genetics Company Details
-
11.17.2 Seattle Genetics Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Seattle Genetics Monoclonal Antibodies Main Business and Markets Served
-
11.17.4 Seattle Genetics Monoclonal Antibodies Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 AbbVie
-
11.18.1 AbbVie Company Details
-
11.18.2 AbbVie Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 AbbVie Monoclonal Antibodies Main Business and Markets Served
-
11.18.4 AbbVie Monoclonal Antibodies Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Takeda
-
11.19.1 Takeda Company Details
-
11.19.2 Takeda Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Takeda Monoclonal Antibodies Main Business and Markets Served
-
11.19.4 Takeda Monoclonal Antibodies Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Johnson & Johnson
-
11.20.1 Johnson & Johnson Company Details
-
11.20.2 Johnson & Johnson Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Johnson & Johnson Monoclonal Antibodies Main Business and Markets Served
-
11.20.4 Johnson & Johnson Monoclonal Antibodies Product Portfolio
-
11.20.5 Recent Research and Development Strategies
12 Global Monoclonal Antibodies Market Outlook by Types and Applications to 2028
-
12.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Infection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Hematological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Monoclonal Antibodies Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Autoimmune and inflammatory diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Respiratory diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Monoclonal Antibodies Market Analysis and Outlook to 2028
-
13.1 Global Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.2.2 Canada Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.2.3 Mexico Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.2 UK Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.3 Spain Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.4 Belgium Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.5 France Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.6 Italy Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.7 Denmark Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.8 Finland Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.9 Norway Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.10 Sweden Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.11 Poland Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.12 Russia Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.3.13 Turkey Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.2 Japan Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.3 India Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.4 South Korea Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.8 Thailand Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.9 Singapore Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.11 Philippines Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5.2 Colombia Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5.3 Chile Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5.4 Argentina Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5.6 Peru Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.6.3 Oman Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.6.4 Qatar Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.7.2 South Africa Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.7.3 Egypt Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.7.4 Algeria Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Monoclonal Antibodies Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Monoclonal Antibodies Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Monoclonal Antibodies
-
Figure of Monoclonal Antibodies Picture
-
Table Global Monoclonal Antibodies Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Monoclonal Antibodies Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Infection Consumption and Growth Rate (2017-2022)
-
Figure Global Hematological Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune and inflammatory diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption by Country (2017-2022)
-
Table North America Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure United States Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Canada Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Mexico Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table Europe Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure Germany Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure UK Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Spain Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Belgium Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure France Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Italy Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Denmark Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Finland Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Norway Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Sweden Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Poland Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Russia Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Turkey Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table APAC Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure China Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Japan Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure India Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Thailand Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Singapore Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Philippines Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table South America Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure Brazil Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Colombia Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Chile Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Argentina Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Peru Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table GCC Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure Bahrain Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Oman Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Qatar Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table Africa Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure Nigeria Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure South Africa Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Egypt Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Algeria Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table Oceania Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure Australia Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table MedImmune Company Details
-
Table MedImmune Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune Monoclonal Antibodies Main Business and Markets Served
-
Table MedImmune Monoclonal Antibodies Product Portfolio
-
Table mmunogen Company Details
-
Table mmunogen Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table mmunogen Monoclonal Antibodies Main Business and Markets Served
-
Table mmunogen Monoclonal Antibodies Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Monoclonal Antibodies Main Business and Markets Served
-
Table Eli Lilly Monoclonal Antibodies Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Monoclonal Antibodies Main Business and Markets Served
-
Table Novartis Monoclonal Antibodies Product Portfolio
-
Table BMS Company Details
-
Table BMS Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table BMS Monoclonal Antibodies Main Business and Markets Served
-
Table BMS Monoclonal Antibodies Product Portfolio
-
Table Formation Biologics Company Details
-
Table Formation Biologics Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Formation Biologics Monoclonal Antibodies Main Business and Markets Served
-
Table Formation Biologics Monoclonal Antibodies Product Portfolio
-
Table Human Genome Sciences Company Details
-
Table Human Genome Sciences Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Human Genome Sciences Monoclonal Antibodies Main Business and Markets Served
-
Table Human Genome Sciences Monoclonal Antibodies Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Monoclonal Antibodies Main Business and Markets Served
-
Table Pfizer Monoclonal Antibodies Product Portfolio
-
Table Stemcentrx Company Details
-
Table Stemcentrx Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stemcentrx Monoclonal Antibodies Main Business and Markets Served
-
Table Stemcentrx Monoclonal Antibodies Product Portfolio
-
Table Synthon Biopharmaceuticals Company Details
-
Table Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synthon Biopharmaceuticals Monoclonal Antibodies Main Business and Markets Served
-
Table Synthon Biopharmaceuticals Monoclonal Antibodies Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Monoclonal Antibodies Main Business and Markets Served
-
Table GlaxoSmithKline Monoclonal Antibodies Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Monoclonal Antibodies Main Business and Markets Served
-
Table Amgen Monoclonal Antibodies Product Portfolio
-
Table Genmab Company Details
-
Table Genmab Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genmab Monoclonal Antibodies Main Business and Markets Served
-
Table Genmab Monoclonal Antibodies Product Portfolio
-
Table Roche Company Details
-
Table Roche Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Monoclonal Antibodies Main Business and Markets Served
-
Table Roche Monoclonal Antibodies Product Portfolio
-
Table Teva Company Details
-
Table Teva Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Monoclonal Antibodies Main Business and Markets Served
-
Table Teva Monoclonal Antibodies Product Portfolio
-
Table Merck Company Details
-
Table Merck Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Monoclonal Antibodies Main Business and Markets Served
-
Table Merck Monoclonal Antibodies Product Portfolio
-
Table Seattle Genetics Company Details
-
Table Seattle Genetics Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Monoclonal Antibodies Main Business and Markets Served
-
Table Seattle Genetics Monoclonal Antibodies Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Monoclonal Antibodies Main Business and Markets Served
-
Table AbbVie Monoclonal Antibodies Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Monoclonal Antibodies Main Business and Markets Served
-
Table Takeda Monoclonal Antibodies Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Monoclonal Antibodies Main Business and Markets Served
-
Table Johnson & Johnson Monoclonal Antibodies Product Portfolio
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune and inflammatory diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Table North America Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure United States Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure Germany Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure China Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure Brazil Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure Australia Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
